Correlation Between Navidea Biopharmaceutica and Aravive
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Aravive, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Aravive.
Diversification Opportunities for Navidea Biopharmaceutica and Aravive
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Navidea and Aravive is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Aravive go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and Aravive
Given the investment horizon of 90 days Navidea Biopharmaceuticals is expected to generate 0.98 times more return on investment than Aravive. However, Navidea Biopharmaceuticals is 1.02 times less risky than Aravive. It trades about -0.5 of its potential returns per unit of risk. Aravive is currently generating about -0.83 per unit of risk. If you would invest 11.00 in Navidea Biopharmaceuticals on September 12, 2024 and sell it today you would lose (1.04) from holding Navidea Biopharmaceuticals or give up 9.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Navidea Biopharmaceuticals vs. Aravive
Performance |
Timeline |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Navidea Biopharmaceutica and Aravive Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Navidea Biopharmaceutica and Aravive
The main advantage of trading using opposite Navidea Biopharmaceutica and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |